Efficacy of percutaneous balloon compression of the trigeminal ganglion guided by 3D-slicer printed guide plate in the treatment of trigeminal neuralgia
10.3760/cma.j.cn431274-20241211-01844
- VernacularTitle:3D-Slicer打印导板引导下经皮三叉神经半月节球囊压迫术治疗三叉神经痛的效果
- Author:
Chunchun YANG
1
;
Didi PAN
1
;
Xuelei HOU
1
;
Wang ZHANG
1
Author Information
1. 阜阳市人民医院神经外科，阜阳 236000
- Publication Type:Journal Article
- Keywords:
Trigeminal neuralgia;
Printing, three-dimensional;
Trigeminal gasserian ganglion;
Percutaneous balloon compression
- From:
Journal of Chinese Physician
2025;27(9):1330-1334
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the efficacy of 3D-Slicer printed guide-assisted percutaneous balloon compression (PBC) of the trigeminal ganglion in the treatment of trigeminal neuralgia (TN).Methods:A total of 100 patients with TN admitted to the Department of Neurosurgery at the People′s Hospital of Fuyang from June 2022 to June 2024 were selected and randomly divided into a control group and a study group, with 50 patients in each group. The control group underwent conventional PBC, while the study group received 3D-Slicer printed guide-assisted PBC. The two groups were compared in terms of operation time, number of punctures, puncture time, number of mobile X-ray exposures, first-attempt success rate, immediate postoperative Barrow Neurological Institute (BNI) pain intensity score, and incidence of complications.Results:The study group showed significantly shorter operation time, fewer punctures, shorter puncture time, and fewer mobile X-ray exposures compared to the control group (all P<0.05). The first-attempt success rate was also higher in the study group ( P<0.05). There were no significant differences in the postoperative BNI pain intensity scores or complication rates between the two groups (all P>0.05). Conclusions:3D-Slicer printed guide-assisted PBC for TN significantly shortens operation and puncture time, reduces the number of punctures and mobile X-ray exposures, and improves the first-attempt success rate, making it worthy of clinical promotion and application.
